Edwards Lifesciences (EW) net assets (shareholders' equity)

Net assets · fiscal 2025
$10.34B

Edwards Lifesciences (EW) had net assets of $10.34B at the end of fiscal 2025 (December 31, 2025). That is 3.4% higher than the $10.00B of fiscal 2024. Figures as of 18 Nov 2026, 19:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$10.34B
Change on fiscal 2024
+3.4%
Growth, 5 years
+17.7% a year
Growth, 10 years
+15.2% a year
Highest on record
$10.34Bfiscal 2025
Lowest on record
$878.80Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Edwards Lifesciences net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 17.7% a year; over ten years the rate was 15.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $10.34B in fiscal 2025 and the lowest $878.80M in fiscal 2008.

History · 18 fiscal years

Net assets by fiscal year

Edwards Lifesciences net assets (shareholders' equity), year by year

Edwards Lifesciences (EW) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$10.34B 3.4% up
2024$10.00B 50.4% up
2023$6.65B 14.5% up
2022$5.81B 0.5% down
2021$5.84B 27.6% up
2020$4.57B 10.3% up
2019$4.15B 32.1% up
2018$3.14B 6.2% up
2017$2.96B 12.9% up
2016$2.62B 4.6% up
2015$2.50B 14.2% up
2014$2.19B 41.9% up
2013$1.54B 5.3% up
2012$1.47B 10.5% up
2011$1.33B 1.5% up
2010$1.31B 13.0% up
2009$1.16B 31.8% up
2008$878.80M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on EW

Edwards Lifesciences, figure by figure

Edwards Lifesciences (EW) overview: price, valuation and scorecardAll health care companies by market value

Edwards Lifesciences net assets (shareholders' equity): questions and answers

What are Edwards Lifesciences's net assets?

Edwards Lifesciences (EW) had net assets of $10.34B at the end of fiscal 2025 (December 31, 2025). That is 3.4% higher than the $10.00B of fiscal 2024.

What is the growth rate of Edwards Lifesciences's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 17.7% a year; over ten years the rate was 15.2% a year.

What are the highest and lowest net assets figures on record for Edwards Lifesciences?

Across the 18 fiscal years on record (2008–2025), the highest was $10.34B in fiscal 2025 and the lowest $878.80M in fiscal 2008.

How is Edwards Lifesciences's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Edwards Lifesciences it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edwards Lifesciences (EW) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/EW/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.